No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisib

Barrientos, JC, Hillmen, P orcid.org/0000-0001-5617-4403, Salles, G et al. (8 more authors) (2020) No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisib. Leukemia & Lymphoma. ISSN 1042-8194

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Keywords: Hemorrhage; thrombocytopenia; PI3K inhibitor; antiplatelet; anticoagulant
Dates:
  • Accepted: 26 October 2020
  • Published (online): 10 December 2020
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 21 Jan 2021 17:45
Last Modified: 21 Jan 2021 17:45
Status: Published online
Publisher: Taylor and Francis
Identification Number: https://doi.org/10.1080/10428194.2020.1845339
Related URLs:

Export

Statistics